Douglas Furlong

Chairman; Principal Owner

3 past transactions

Pantheon Vision

Seed Round in 2024
Pantheon Vision is an early-stage ophthalmic medical device company focused on developing bioengineered corneal implants. Their mission is to treat corneal blindness and restore vision worldwide. They aim to create products that enhance surgical procedures, ensuring safety, effectiveness, and global accessibility. By reducing dependence on donor tissue, Pantheon Vision enables patients to regain their eyesight.

Pantheon Vision

Seed Round in 2023
Pantheon Vision is an early-stage ophthalmic medical device company focused on developing bioengineered corneal implants. Their mission is to treat corneal blindness and restore vision worldwide. They aim to create products that enhance surgical procedures, ensuring safety, effectiveness, and global accessibility. By reducing dependence on donor tissue, Pantheon Vision enables patients to regain their eyesight.

Toku Eyes

Seed Round in 2021
Toku Eyes creates diagnostic and screening tools to eliminate doctors' preventable health and vision deterioration. The company's tools provide a collection of artificial intelligence engines, each specialized in using a different imaging modality for diagnostics, prognostics, or health assessment purposes, allowing clinicians to aid in the prevention of diabetes and preventable blindness.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.